Daratumumab

From WikiMD.org
Jump to navigation Jump to search
Daratumumab
TermDaratumumab
Short definitionDaratumumab - (pronounced) (DAYR-uh-TOOM-yoo-mab) medicine used alone or with other medicines to treat adults with multiple myeloma. It is used in patients whose cancer has been newly diagnosed and who may or may not be treated with autologous stem cell transplantation. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Daratumumab - (pronounced) (DAYR-uh-TOOM-yoo-mab) medicine used alone or with other medicines to treat adults with multiple myeloma. It is used in patients whose cancer has been newly diagnosed and who may or may not be treated with autologous stem cell transplantation. Daratumumab is also used in patients whose cancer has come back or has not improved after treatment with one or more anticancer therapies. It is also being studied in the treatment of other types of cancer. Daratumumab attaches to a protein called CD38, which is found on some types of immune cells and cancer cells, including myeloma cells. Daratumumab can block CD38 and help the immune system kill cancer cells. It's a type of monoclonal antibody. Also called Darzalex

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski